NO20024723L - FremgangsmÕte for in vitro molekylir utvikling av antilegeme- funksjoner - Google Patents

FremgangsmÕte for in vitro molekylir utvikling av antilegeme- funksjoner

Info

Publication number
NO20024723L
NO20024723L NO20024723A NO20024723A NO20024723L NO 20024723 L NO20024723 L NO 20024723L NO 20024723 A NO20024723 A NO 20024723A NO 20024723 A NO20024723 A NO 20024723A NO 20024723 L NO20024723 L NO 20024723L
Authority
NO
Norway
Prior art keywords
framework
procedure
body functions
vitro molecular
nucleic acid
Prior art date
Application number
NO20024723A
Other languages
English (en)
Other versions
NO330262B1 (no
NO20024723D0 (no
Inventor
Mats Ohlin
Eskil Soederlind
Roland Carlsson
Original Assignee
Bioinvent Int Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent Int Ab filed Critical Bioinvent Int Ab
Publication of NO20024723D0 publication Critical patent/NO20024723D0/no
Publication of NO20024723L publication Critical patent/NO20024723L/no
Publication of NO330262B1 publication Critical patent/NO330262B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B10/00—Directed molecular evolution of macromolecules, e.g. RNA, DNA or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Ecology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20024723A 2000-04-05 2002-10-02 Fremgangsmate for in vitro molekylaer utvikling av antistoff virkning, in vitro. NO330262B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008419.4A GB0008419D0 (en) 2000-04-05 2000-04-05 A method for invitro molecular evolution of antibody function
PCT/EP2001/004065 WO2001075091A2 (en) 2000-04-05 2001-04-04 A method for in vitro molecular evolution of antibody function

Publications (3)

Publication Number Publication Date
NO20024723D0 NO20024723D0 (no) 2002-10-02
NO20024723L true NO20024723L (no) 2002-12-02
NO330262B1 NO330262B1 (no) 2011-03-14

Family

ID=9889301

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024723A NO330262B1 (no) 2000-04-05 2002-10-02 Fremgangsmate for in vitro molekylaer utvikling av antistoff virkning, in vitro.

Country Status (11)

Country Link
US (2) US20030153038A1 (no)
EP (1) EP1268801B1 (no)
JP (1) JP4842490B2 (no)
AT (1) ATE269900T1 (no)
AU (2) AU5225301A (no)
CA (1) CA2402240C (no)
DE (1) DE60103988T2 (no)
GB (1) GB0008419D0 (no)
IL (2) IL151743A0 (no)
NO (1) NO330262B1 (no)
WO (1) WO2001075091A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE384129T1 (de) 2001-11-22 2008-02-15 Univ Keio Künstliche antikörperbibliothek mit super- repertoire
US7135310B2 (en) 2002-04-24 2006-11-14 The Regents Of The University Of California Method to amplify variable sequences without imposing primer sequences
JP2006508638A (ja) 2002-05-22 2006-03-16 エスバテック・アーゲー 細胞内環境において向上した安定性を示す免疫グロブリンフレームワークおよびそれを同定する方法
GB2400851B (en) * 2003-04-25 2004-12-15 Bioinvent Int Ab Identifying binding of a polypeptide to a polypeptide target
US20050053989A1 (en) * 2003-08-27 2005-03-10 Gil Sharon Libraries of recombinant chimeric proteins
WO2005059176A1 (en) * 2003-12-15 2005-06-30 Institut Pasteur Repertoire determination of a lymphocyte b population
DE60326052D1 (de) * 2003-12-15 2009-03-19 Pasteur Institut Ermittlung des Repertoires von B-Lymphozyten Populationen
GB0500703D0 (en) * 2005-01-14 2005-02-23 Bioinvent Int Ab Molecular biology method
US20090075378A1 (en) * 2007-02-20 2009-03-19 Anaptysbio, Inc. Somatic hypermutation systems
CA2742969A1 (en) 2008-11-07 2010-05-14 Fabrus Llc Anti-dll4 antibodies and uses thereof
CA2780221A1 (en) 2009-11-04 2011-05-12 Fabrus Llc Methods for affinity maturation-based antibody optimization
JP6616284B2 (ja) * 2013-04-23 2019-12-04 ザ ユニバーシティ コート オブ ザ ユニバーシティ オブ アバディーン 特異的結合分子の人工ライブラリー
EP3561703B1 (de) * 2018-04-25 2021-01-20 Bayer AG Identifizieren der paarung von variablen domänen aus leichten und schweren ketten von antikörpern
EP3833685A4 (en) 2018-07-08 2022-08-17 Specifica Inc. ANTIBODY LIBRARIES WITH FEATURES FOR MAXIMIZED ANTIBODY DEVELOPMENT

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440859A (en) * 1977-05-27 1984-04-03 The Regents Of The University Of California Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4704362A (en) * 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
LU88258I2 (no) * 1978-12-22 1994-02-03
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4678751A (en) * 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
US4757006A (en) * 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US4677063A (en) * 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4810648A (en) * 1986-01-08 1989-03-07 Rhone Poulenc Agrochimie Haloarylnitrile degrading gene, its use, and cells containing the gene
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
ES2176484T3 (es) * 1995-08-18 2002-12-01 Morphosys Ag Bancos de proteinas/(poli)peptidos.
GB9701425D0 (en) * 1997-01-24 1997-03-12 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
WO1999006834A2 (en) * 1997-08-04 1999-02-11 Ixsys, Incorporated Methods for identifying ligand specific binding molecules

Also Published As

Publication number Publication date
CA2402240C (en) 2012-02-28
GB0008419D0 (en) 2000-05-24
DE60103988T2 (de) 2005-07-14
NO330262B1 (no) 2011-03-14
US20030153038A1 (en) 2003-08-14
ATE269900T1 (de) 2004-07-15
DE60103988D1 (de) 2004-07-29
AU5225301A (en) 2001-10-15
JP4842490B2 (ja) 2011-12-21
EP1268801B1 (en) 2004-06-23
IL151743A (en) 2009-02-11
IL151743A0 (en) 2003-04-10
JP2003529368A (ja) 2003-10-07
WO2001075091A2 (en) 2001-10-11
WO2001075091A3 (en) 2002-04-18
US20120077710A1 (en) 2012-03-29
AU2001252253B2 (en) 2004-04-08
EP1268801A2 (en) 2003-01-02
NO20024723D0 (no) 2002-10-02
CA2402240A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
NO20024723L (no) FremgangsmÕte for in vitro molekylir utvikling av antilegeme- funksjoner
Ahn et al. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
TW200516083A (en) Methods for making dual specificity antibodies
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
ATE520466T1 (de) Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen
FR2784580B1 (fr) Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
DK1073905T3 (da) Fremgangsmåder til selektering af internaliserings-antistoffer
DE60214358D1 (de) Zeitskalenmodifikation von signalen mit spezifischem verfahren je nach ermitteltem signaltyp
BR0108797A (pt) Método e sistema para atualização de um arquivo compactado de um arquivo de computador
DE60234207D1 (de) Verfahren und system zur verringerung der aktualisierungs-häufigkeit
ATE546013T1 (de) System und verfahren zur einfügung von lokalen metadaten
ATE419388T1 (de) Nukleinsäureanreicherung
DK0702728T3 (da) Magnetisk cyklusreaktion
DE60213803D1 (en) Happier mapping
DK1272843T3 (da) Fremgangsmåde til identifikation af regulatorer af protein-AGE-dannelse
DE69929470D1 (de) Genkonstrukte für genimmunisierung
ATE361334T1 (de) Verfahren zur herstellung von hochreinem polycarbonat
EA200600459A1 (ru) Способ получения цитотоксических лимфоцитов
ATE366120T1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
EA200100160A1 (ru) Новые способы идентификации биомолекул лигандов и мишеней
AU6177101A (en) In vitro evolution of nucleic acids and encoded polypeptide
Gabor et al. Evaluation for social workers
AU1278801A (en) Method for generating information related to the molecular structure of a biomolecule
AU2003283240A1 (en) Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells
ATE347913T1 (de) Verfahren zur identifizierung von wächter- lymphknoten

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees